{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:34:54Z","timestamp":1772688894189,"version":"3.50.1"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/100006756","name":"Brigham Young University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1093\/jac\/dky085","type":"journal-article","created":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T07:07:34Z","timestamp":1519456054000},"page":"1537-1545","source":"Crossref","is-referenced-by-count":33,"title":["Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms"],"prefix":"10.1093","volume":"73","author":[{"given":"Marjan M","family":"Hashemi","sequence":"first","affiliation":[{"name":"Department of Chemistry and Biochemistry, Brigham Young University, C100 BNSN, Provo, UT 84602, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Rovig","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Brigham Young University, C100 BNSN, Provo, UT 84602, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett S","family":"Holden","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Brigham Young University, C100 BNSN, Provo, UT 84602, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddison F","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Brigham Young University, C100 BNSN, Provo, UT 84602, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Brigham Young University, C100 BNSN, Provo, UT 84602, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Brigham Young University, C100 BNSN, Provo, UT 84602, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Hilton","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Brigham Young University, C100 BNSN, Provo, UT 84602, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron L","family":"Zaugg","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Brigham Young University, C100 BNSN, Provo, UT 84602, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel W","family":"Ellis","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Brigham Young University, C100 BNSN, Provo, UT 84602, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connor D","family":"Yost","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Brigham Young University, C100 BNSN, Provo, UT 84602, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M","family":"Finnegan","sequence":"additional","affiliation":[{"name":"Extherid Biosciences, Jackson, WY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles K","family":"Kistler","sequence":"additional","affiliation":[{"name":"Extherid Biosciences, Jackson, WY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth L","family":"Berkow","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenglou","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Brigham Young University, C100 BNSN, Provo, UT 84602, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn R","family":"Lockhart","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marnie","family":"Peterson","sequence":"additional","affiliation":[{"name":"Extherid Biosciences, Jackson, WY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul B","family":"Savage","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Brigham Young University, C100 BNSN, Provo, UT 84602, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"key":"key\n\t\t\t\t20180518035634_dky085-B1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180518035634_dky085-B2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/cid\/ciw696","article-title":"Emergence of Candida auris: an international call to arms","volume":"64","author":"Clancy","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180518035634_dky085-B3","doi-asserted-by":"crossref","first-page":"e1006290.","DOI":"10.1371\/journal.ppat.1006290","article-title":"Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally","volume":"13","author":"Chowdhary","year":"2017","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20180518035634_dky085-B4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.NAJ.0000515233.51795.b3","article-title":"Clinical alert: Candida auris","volume":"117","author":"Todd","year":"2017","journal-title":"Am J Nurs"},{"key":"key\n\t\t\t\t20180518035634_dky085-B5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/IDR.S116229","article-title":"Current perspective on emergence, diagnosis and drug resistance in Candida auris","volume":"10","author":"Sarma","year":"2017","journal-title":"Infect Drug Resist"},{"key":"key\n\t\t\t\t20180518035634_dky085-B6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.15585\/mmwr.mm6619a7","article-title":"Ongoing transmission of Candida auris in health care facilities \u2014 United States, June 2016\u2013May 2017","volume":"66","author":"Tsay","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180518035634_dky085-B7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/myc.12647","article-title":"The first cases of Candida auris candidaemia in Oman","volume":"60","author":"Mohsin","year":"2017","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20180518035634_dky085-B8","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/jac\/dkx034","article-title":"Candida auris candidaemia in Indian ICUs: analysis of risk factors","volume":"72","author":"Rudramurthy","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035634_dky085-B9","doi-asserted-by":"crossref","first-page":"e00485","DOI":"10.1128\/AAC.00485-17","article-title":"Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated epidemiological cutoff values","volume":"61","author":"Arendrup","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180518035634_dky085-B10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14787210.2017.1328279","article-title":"Drug development challenges and strategies to address emerging and resistant fungal pathogens","volume":"15","author":"McCarthy","year":"2017","journal-title":"Exp Rev Anti-Infect Therapy"},{"key":"key\n\t\t\t\t20180518035634_dky085-B11","doi-asserted-by":"crossref","first-page":"97.","DOI":"10.3389\/fmicb.2014.00097","article-title":"Defensins: antifungal lessons from eukaryotes","volume":"5","author":"Silva","year":"2014","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20180518035634_dky085-B12","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1128\/EC.00093-14","article-title":"Interplay between Candida albicans and the antimicrobial peptide armory","volume":"13","author":"Swidergall","year":"2014","journal-title":"Eukaryot Cell"},{"key":"key\n\t\t\t\t20180518035634_dky085-B13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.fbr.2012.11.001","article-title":"Commercialization of antifungal peptides","volume":"26","author":"Duncan","year":"2013","journal-title":"Fungal Biol Rev"},{"key":"key\n\t\t\t\t20180518035634_dky085-B14","doi-asserted-by":"crossref","first-page":"12280","DOI":"10.3390\/molecules190812280","article-title":"Antifungal plant defensins: mechanisms of action and production","volume":"19","author":"Vriens","year":"2014","journal-title":"Molecules"},{"key":"key\n\t\t\t\t20180518035634_dky085-B15","doi-asserted-by":"crossref","first-page":"1000141","DOI":"10.4172\/2472-1212.1000141","article-title":"Ceragenins as mimics of endogenous antimicrobial peptides","volume":"3","author":"Hashemi","year":"2017","journal-title":"J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180518035634_dky085-B16","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/ar700270t","article-title":"Ceragenins: cholic acid-based mimics of antimicrobial peptides","volume":"41","author":"Lai","year":"2008","journal-title":"Acc Chem Res"},{"key":"key\n\t\t\t\t20180518035634_dky085-B17","doi-asserted-by":"crossref","first-page":"e00292-17","DOI":"10.1128\/AAC.00292-17","article-title":"Susceptibility of colistin-resistant, Gram-negative bacteria to antimicrobial peptides and ceragenins","volume":"61","author":"Hashemi","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180518035634_dky085-B18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijantimicag.2015.08.003","article-title":"CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates","volume":"46","author":"Vila-Farr\u00e9s","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180518035634_dky085-B19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/2211-5463.12235","article-title":"Antimicrobial ceragenins inhibit biofilms and affect mammalian cell viability and migration in vitro","volume":"7","author":"Olekson","year":"2017","journal-title":"FEBS Open Bio"},{"key":"key\n\t\t\t\t20180518035634_dky085-B20","doi-asserted-by":"crossref","first-page":"e0157242","DOI":"10.1371\/journal.pone.0157242","article-title":"Candidacidal activity of selected ceragenins and human cathelicidin LL-37 in experimental settings mimicking infection sites","volume":"11","author":"Durnas","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180518035634_dky085-B21","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.bbamem.2017.06.005","article-title":"Synthetic antimicrobial peptides of the halcitines family disturb the membrane integrity of Candida cells","volume":"1859","author":"Kodedov\u00e1","year":"2017","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20180518035634_dky085-B22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.peptides.2015.04.018","article-title":"Fighting microbial infections: a lesson from amphibian skin-derived esculentin-1 peptides","volume":"71","author":"Mangoni","year":"2015","journal-title":"Peptides"},{"key":"key\n\t\t\t\t20180518035634_dky085-B23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12275-014-3630-2","article-title":"Responses of Candida albicans to the human antimicrobial peptide LL-37","volume":"52","author":"Tsai","year":"2014","journal-title":"J Microbiol"},{"key":"key\n\t\t\t\t20180518035634_dky085-B24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1042\/BCJ20161039","article-title":"Scolopendin, an antimicrobial peptide from centipede, attenuates mitochondrial functions and triggers apoptosis in Candida albicans","volume":"474","author":"Lee","year":"2017","journal-title":"Biochem J"},{"key":"key\n\t\t\t\t20180518035634_dky085-B25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/1574-6968.12450","article-title":"Melittin triggers apoptosis in Candida albicans through the reactive oxygen species-mediated mitochondria\/caspase-dependent pathway","volume":"355","author":"Lee","year":"2014","journal-title":"FEMS Microbiol Lett"},{"key":"key\n\t\t\t\t20180518035634_dky085-B26","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.peptides.2011.08.018","article-title":"Antifungal action of human cathelicidin fragment (LL13-37) on Candida albicans","volume":"32","author":"Wong","year":"2011","journal-title":"Peptides"},{"key":"key\n\t\t\t\t20180518035634_dky085-B27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbrc.2010.02.138","article-title":"Melittin induces apoptotic features in Candida albicans","volume":"394","author":"Park","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20180518035634_dky085-B28","doi-asserted-by":"crossref","first-page":"4610.","DOI":"10.1038\/s41598-017-04653-1","article-title":"Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13","volume":"7","author":"Niemirowicz","year":"2017","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20180518035634_dky085-B29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2106\/JBJS.N.00840","article-title":"Local delivery of the cationic steroid antibiotic CSA-90 enables osseous union in a rat open fracture model of Staphylococcus aureus infection","volume":"97","author":"Schindeler","year":"2015","journal-title":"J Bone Joint Surg Am"},{"key":"key\n\t\t\t\t20180518035634_dky085-B30","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1128\/AAC.00653-15","article-title":"Bactericidal activity of ceragenin CSA-13 in cell culture and in an animal model of peritoneal infection","volume":"59","author":"Bucki","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180518035634_dky085-B31","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/jbm.b.32924","article-title":"Model development for determining the efficacy of a combination coating for the prevention of perioperative device related infections: a pilot study","volume":"101","author":"Sinclair","year":"2013","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"key\n\t\t\t\t20180518035634_dky085-B32","doi-asserted-by":"crossref","first-page":"8641","DOI":"10.1016\/j.biomaterials.2012.08.003","article-title":"In vivo efficacy of a silicone-cationic steroid antimicrobial coating to prevent implant-related infection","volume":"33","author":"Williams","year":"2012","journal-title":"Biomaterials"},{"key":"key\n\t\t\t\t20180518035634_dky085-B33","doi-asserted-by":"crossref","first-page":"13642","DOI":"10.1021\/ja046909p","article-title":"Origins of cell selectivity of cationic steroid antibiotics","volume":"126","author":"Ding","year":"2004","journal-title":"J Am Chem Soc"},{"key":"key\n\t\t\t\t20180518035634_dky085-B34","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1021\/ol0062704","article-title":"Preparation and characterization of cholic acid-derived antimicrobial agents with controlled stabilities","volume":"2","author":"Guan","year":"2000","journal-title":"Org Lett"},{"key":"key\n\t\t\t\t20180518035634_dky085-B35","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/jac\/dkx008","article-title":"In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis","volume":"72","author":"Boikov","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035634_dky085-B36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jac\/dkn486","article-title":"Antifungal mechanisms supporting boric acid therapy of Candida vaginitis","volume":"63","author":"De Seta","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035634_dky085-B37","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1093\/jac\/dkw316","article-title":"In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species","volume":"71","author":"Valent\u00edn","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035634_dky085-B38","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41598-017-01686-4","article-title":"The antifungal effects and mechanical properties of silver bromide\/cationic polymer nano-composite-modified Poly-methyl methacrylate-based dental resin","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20180518035634_dky085-B39","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Third Informational Supplement M27-A3","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"key\n\t\t\t\t20180518035634_dky085-B40","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/jac\/dkm350","article-title":"Correlation of posaconazole minimum fungicidal concentration and time\u2013kill test against nine Candida species","volume":"60","author":"S\u00f3cz\u00f3","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035634_dky085-B41","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1021\/bp070334t","article-title":"Quantifying metabolic activity of filamentous fungi using a colorimetric XTT assay","volume":"24","author":"Moss","year":"2008","journal-title":"Biotechnol Prog"},{"key":"key\n\t\t\t\t20180518035634_dky085-B42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.mimet.2012.12.003","article-title":"A mucosal model to study microbial biofilm development and anti-biofilm therapeutics","volume":"92","author":"Anderson","year":"2013","journal-title":"J Microbiol Methods"},{"key":"key\n\t\t\t\t20180518035634_dky085-B43","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jac\/dkl521","article-title":"Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole","volume":"59","author":"Bruzual","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035634_dky085-B44","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/jac\/dkt365","article-title":"Anti-Candida albicans biofilm effect of novel heterocyclic compounds","volume":"69","author":"Kagan","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035634_dky085-B45","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/jac\/dkr512","article-title":"Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms","volume":"67","author":"Khan","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035634_dky085-B46","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/jac\/dkp242","article-title":"Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis","volume":"64","author":"Lazzell","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035634_dky085-B47","doi-asserted-by":"crossref","first-page":"e02396","DOI":"10.1128\/AAC.02396-16","article-title":"The emerging Candida auris: characterization of growth phenotype, virulence factors, antifungal activity, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation","volume":"61","author":"Larkin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180518035634_dky085-B48","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/13693786.2010.493563","article-title":"Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea","volume":"49","author":"Oh","year":"2011","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20180518035634_dky085-B49","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/mbo3.77","article-title":"Study of the effect of antimicrobial peptide mimic, CSA-13, on an established biofilm formed by Pseudomonas aeruginosa","volume":"2","author":"Nagant","year":"2013","journal-title":"Microbiol Open"},{"key":"key\n\t\t\t\t20180518035634_dky085-B50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jac\/dkx347","article-title":"Preclinical testing of a broad-spectrum antimicrobial endotracheal tube coated with an innate immune synthetic mimic","volume":"73","author":"Hashemi","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035634_dky085-B51","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1365-2672.2012.05297.x","article-title":"Effect of pluronic acid F-127 on the toxicity towards eukaryotic cells of CSA-13, a cationic steroid analogue of antimicrobial peptides","volume":"112","author":"Nagant","year":"2012","journal-title":"J Appl Microbiol"},{"key":"key\n\t\t\t\t20180518035634_dky085-B52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2672.2010.04874.x","article-title":"Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections","volume":"110","author":"Leszczy\u0144ska","year":"2011","journal-title":"J Appl Microbiol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/6\/1537\/24804887\/dky085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T16:09:19Z","timestamp":1570810159000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/6\/1537\/4960903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,4,4]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky085","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,4,4]]}}}